logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (iv) All outpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates23.248.764.965.761.759.855.849.414872032271
Cocaine9.019.323.524.927.928.529.618.0582469371
Stimulants3.64.52.72.32.42.32.35.4103042655
Hypnotics and sedatives1.51.01.32.33.54.98.212.850221509
Hallucinogens0.20.30.20.20.10.10.10.0685262
Volatile substances0.50.60.00.00.00.10.10.3954310
Cannabis 60.624.76.84.03.43.12.68.06021422404
Other substances 1.40.80.50.50.91.21.36.124831222
Total3660812725163435292941530076703739333128662870004

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE,EE, IE, EL, ES, FR, IT, CY, LU, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, UK, HR 

 Last data available from Spain and Poland refer to 2008. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-107 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 29 June 2011